A thousand words about the link between red blood cell distribution width and heart failure

Pawel Nowinka; Eduoard Korab-Karpinski; Przemysław Guzik

doi:10.20883/jms.338

Authors

Pawel Nowinka Department of Cardiology‑Pulmonology, Heliodor Swiecicki University Hospital, Poznan University of Medical Sciences, Poland https://orcid.org/0000-0002-2161-2693
Eduoard Korab-Karpinski Department of Cardiology‑Intensive Therapy, Poznan University of Medical Sciences, Poland https://orcid.org/0000-0003-4189-8833
Przemysław Guzik Department of Cardiology‑Intensive Therapy, Poznan University of Medical Sciences, Poland http://orcid.org/0000-0001-9052-5027

DOI:

https://doi.org/10.20883/jms.338

Keywords:

adverse clinical outcomes, heart failure, mortality, red blood cell distribution width

Abstract

A link between the red blood cell distribution width (RDW) and clinical outcomes in heart failure (HF) was reported for the first time in 2007. Since then, many studies have shown that an increased RDW is an independent and strong predictor of mortality and morbidity in patients with acute, decompensated or chronic HF. The evidence for such a link comes from dozens of prospective and retrospective studies in which clinical data from hundreds or even thousands of patients were examined. Although many processes such as nutritional deficiencies (e.g. iron, folate, vitamin B12), inflammation (interleukin 6, tumour necrosis factor), malnutrition, renal failure or tissue and organ hypoxia have been proposed, no clear explanation exists or is commonly accepted. This mini‑review summarises the clinical evidence on the increased RDW as a predictor of adverse clinical outcomes in HF patients, and hypothetical mechanisms that might be responsible for this interesting clinical observation.

Downloads

Download data is not yet available.

Author Biography

Przemysław Guzik, Department of Cardiology‑Intensive Therapy, Poznan University of Medical Sciences, Poland

None

References

Task Force Members, McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14:803–69.

Perlstein TS, Weuve J, Pfeffer MA, Beckman JA. Red blood cell distribution width and mortality risk in a community‑based prospective cohort. Arch Intern Med. 2009;169:588–94.

Tsuboi S, Miyauchi K, Kasai T, Ogita M, Dohi T, Miyazaki T, et al. Impact of red blood cell distribution width on long‑term mortality in diabetic patients after percutaneous coronary intervention. Circ J. 2013;77:456–461. http://www.ncbi.nlm.nih.gov/pubmed/23075764. Accessed January 31, 2019.

Nathan SD, Reffett T, Brown AW, Fischer CP, Shlobin OA, Ahmad S, et al. The red cell distribution width as a prognostic indicator in idiopathic pulmonary fibrosis. Chest. 2013;143:1692–8.

Kim J, Kim YD, Song TJ, Park JH, Lee HS, Nam CM, et a. Red blood cell distribution width is associated with poor clinical outcome in acute cerebral infarction. Thromb Haemost. 2012;108:349–56.

Wang F, Pan W, Pan S, Ge J, Wang S, Chen M. Red cell distribution width as a novel predictor of mortality in ICU patients. Ann Med. 2011;43:40–6.

Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, Pfeffer MA, et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol. 2007;50:40–7.

Evans TC, Jehle D. The red blood cell distribution width. J Emerg Med. 1991;9:71–4.

Salvagno GL, Sanchis‑Gomar F, Picanza A, Lippi G. Red blood cell distribution width: A simple parameter with multiple clinical applications. Crit Rev Clin Lab Sci. 2015;52:86–105.

Bessman JD, Gilmer PR, Gardner FH. Improved classification of anemias by MCV and RDW. Am J Clin Pathol. 1983;80:322–6

Alves TCTF, Rays J, Fráguas R, et al. Localized Cerebral Blood Flow Reductions in Patients With Heart Failure: A Study Using 99mTc‑HMPAO SPECT. J Neuroimaging. 2005;15:150–156.

Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B. The severe cardiorenal syndrome: “Guyton revisited”. Eur Heart J. 2005;26:11–17.

Roman DD, Kubo SH, Ormaza S, Francis GS, Bank AJ, Shumway SJ. Memory improvement following cardiac transplantation. J Clin Exp Neuropsychol. 1997;19:692–697.

Sciatti E, Lombardi C, Ravera A, et al. Nutritional Deficiency in Patients with Heart Failure. Nutrients. 2016;8:442.

Förhécz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohászka Z, Jánoskuti L. Red cell distribution width in heart failure: Prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J. 2009;158:659–666.

Vizzardi E, Sciatti E, Bonadei I, Pezzali NL, Lombardi CM, Metra M. Red cell distribution width and chronic heart failure: prognostic role beyond echocardiographic parameters. Monaldi Arch Chest Dis. 2016;84:59.

Chiari MM, Bagnoli R, De Luca P, Monti M, Rampoldi E, Cunietti E. Influence of Acute Inflammation on Iron and Nutritional Status Indexes in Older Inpatients. J Am Geriatr Soc. 1995;43:767–71

Pierce CN, Larson DF. Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device. Perfusion. 2005 2005;20:83–90.

Kalemci S, Akin F, Sarihan A, Sahin C, Zeybek A, Yilmaz N. The relationship between hematological parameters and the severity level of chronic obstructive lung disease. Polish Arch Intern Med. 2018;128:171–177.

Meynaar IA, Knook AH, Coolen S, Le H, Bos MM, Van Der Dijs F, et al. Red cell distribution width as predictor for mortality in critically ill patients. Neth J Med. 2013;71:488–93.

Lu YA, Fan PC, Lee CC, Wu VC, Tian YC, Yang CW, et al. Red cell distribution width associated with adverse cardiovascular outcomes in patients with chronic kidney disease. BMC Nephrol. 2017;18:361.

Pascual‑Figal DA, Bonaque JC, Redondo B, Caro C, Manzano‑Fernandez S, Sánchez‑Mas J, et al. Red blood cell distribution width predicts long‑term outcome regardless of anaemia status in acute heart failure patients. Eur J Heart Fail. 2009; 11:840–6.

van Kimmenade RR, Mohammed AA, Uthamalingam S, van der Meer P, Felker GM, Januzzi Jr JL. Red blood cell distribution width and 1-year mortality in acute heart failure. Eur J Heart Fail. 2010;12:129–36.

Allen LA, Felker GM, Mehra MR, Chiong JR, Dunlap SH, Ghali JK, et al. Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Card Fail. 2010;16:230–8.

Makhoul BF, Khourieh A, Kaplan M, Bahouth F, Aronson D, Azzam ZS. Relation between changes in red cell distribution width and clinical outcomes in acute decompensated heart failure. Int J Cardiol. 2013;167:1412–6.

Muhlestein JB, Lappe DL, Anderson JL, Muhlestein JB, Budge D, May HT, et al. Both initial red cell distribution width (RDW) and change in RDW during heart failure hospitalization are associated with length of hospital stay and 30-day outcomes. Int J Lab Hematol. 2016;38:328–337.

Wasilewski J, Pyka Ł, Hawranek M, Tajstra M, Skrzypek M, Wasiak M, Suliga K, et al. Prognostic value of red blood cell distribution width in patients with left ventricular systolic dysfunction: Insights from the COMMIT‑HF registry. Cardiol J. 2018;25:377–385.

Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation. 2001;103:2055–9.

Sinagra E, Perricone G, Romano C, Cottone M. Heart failure and anti tumor necrosis factor‑alpha in systemic chronic inflammatory diseases. Eur J Intern Med. 2013;24:385–92.

Feldman AM, Combes A, Wagner D, Kadakomi T, Kubota T, Li YY, et al. The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol. 2000;35:537–44.

Divakaran V, Mehta S, Yao D, Hassan S, Simpson S, Wiegerinck E, Swinkels DW, Mann DL, Afshar‑Kharghan V. Hepcidin in anemia of chronic heart failure. Am J Hematol. 2011;86:107–9.

Yčas JW, Horrow JC, Horne BD. Persistent increase in red cell size distribution width after acute diseases: A biomarker of hypoxemia? Clinica Chimica Acta. 2015;448:107–17.

Guzik P, Piskorski J, Wysocki H, Wykrętowicz A. Prospective observational study on predicting adverse clinical outcomes in patients with implanted defibrillating devices–a study rationale, design and principal methods. J Med Sci 2016; 83: 84–88.